YaoGeJu

Company directoryChina company filings

HeFei Amvite Pharmaceutical Co.,Ltd

As of 18 November 2026, for the company name HeFei Amvite Pharmaceutical Co.,Ltd as recorded, the chemical-drug catalogue lists 7 active records with this name as holder; 6 active API registrations list this name as first registered company.

Check drug filings and source records for this company-name string.

Listed by the company name as recorded in the source, without merging affiliated entities.

Page reference

CDE data as of
2026/11/18
Matching scope
Loaded public-source records only

These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.

Drug filings

26 acceptance records as first applicant, grouped into 15 source drug names. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.

头孢克肟颗粒 · No verified English name 3 records · Latest accepted 2026/04/28

Supplement · 2Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600837Supplement2026/04/28HeFei Amvite Pharmaceutical Co.,Ltd; Anhui An Ke Heng Yi Pharma Co., Ltd. romanizedCDE ↗
CYHB2501767Supplement2025/09/04HeFei Amvite Pharmaceutical Co.,Ltd; Anhui An Ke Heng Yi Pharma Co., Ltd. romanizedCDE ↗
CYHS2201935Generic2022/11/18HeFei Amvite Pharmaceutical Co.,Ltd; Anhui An Ke Heng Yi Pharma Co., Ltd. romanizedCDE ↗
地氯雷他定口服溶液 · No verified English name 2 records · Latest accepted 2026/04/23

Supplement · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2600798Supplement2026/04/23HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
CYHB2302494Supplement2023/11/14HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
利伐沙班口崩片 · No verified English name 2 records · Latest accepted 2025/08/23

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2503096Generic2025/08/23HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
CYHS2503095Generic2025/08/23HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
枸橼酸苯海拉明布洛芬片 · No verified English name 2 records · Latest accepted 2025/08/14

Generic · 2

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2502972Generic2025/08/14HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
CYHL2400152Generic2024/07/18HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
Memantine Hydrochloride OD Tablets 3 records · Latest accepted 2025/03/07

Generic · 3

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2500954Generic2025/03/07HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
CYHS2500953Generic2025/03/07HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
CYHS2400349Generic2024/01/25HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
枸地氯雷他定口服溶液 · No verified English name 1 records · Latest accepted 2025/02/14

New drug · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHS2500017New drug2025/02/14HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
头孢地尼颗粒 · No verified English name 2 records · Latest accepted 2024/12/04

Supplement · 1Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHB2402050Supplement2024/12/04HeFei Amvite Pharmaceutical Co.,Ltd; Anhui An Ke Heng Yi Pharma Co., Ltd. romanizedCDE ↗
CYHS2100289Generic2021/03/23HeFei Amvite Pharmaceutical Co.,Ltd; Anhui An Ke Heng Yi Pharma Co., Ltd. romanizedCDE ↗
HY-072808软膏 · No verified English name 4 records · Latest accepted 2024/11/01

New drug · 4

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CXHL2401156New drug2024/11/01HeFei Amvite Pharmaceutical Co.,Ltd; Hefei Yi Gong Pharmaceuticals Co., Ltd. romanizedCDE ↗
CXHL2401155New drug2024/11/01HeFei Amvite Pharmaceutical Co.,Ltd; Hefei Yi Gong Pharmaceuticals Co., Ltd. romanizedCDE ↗
CXHL2400904New drug2024/09/04HeFei Amvite Pharmaceutical Co.,Ltd; Hefei Yi Gong Pharmaceuticals Co., Ltd. romanizedCDE ↗
CXHL2400903New drug2024/09/04HeFei Amvite Pharmaceutical Co.,Ltd; Hefei Yi Gong Pharmaceuticals Co., Ltd. romanizedCDE ↗
Calcium Acetate Oral Solution 1 records · Latest accepted 2024/10/30

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2403678Generic2024/10/30HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
Desmopressin Acetate Oral Solution 1 records · Latest accepted 2023/04/22

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2301129Generic2023/04/22HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
Teriflunomide Tablets 1 records · Latest accepted 2023/02/14

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2300509Generic2023/02/14HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
Ambroxol Hydrochloride Drops 1 records · Latest accepted 2022/12/29

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2202127Generic2022/12/29HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
Rupatadine Fumarate Tablets 1 records · Latest accepted 2022/09/01

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2201426Generic2022/09/01HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
Pregabalin Oral Solution 1 records · Latest accepted 2021/10/21

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS2101844Generic2021/10/21HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
葡萄糖酸钙锌口服溶液 · No verified English name 1 records · Latest accepted 2019/12/10

Generic · 1

Drug filings
Acceptance numberApplication typeAcceptedCompany / applicantView source
CYHS1900826Generic2019/12/10HeFei Amvite Pharmaceutical Co.,LtdCDE ↗

Changes in the last 90 days

0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

  1. No matching records were found in the currently loaded source data; coverage dates are listed below.

Under review

4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Under review
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
利伐沙班口崩片 · No verified English name CYHS2503096Generic2025/08/23HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
利伐沙班口崩片 · No verified English name CYHS2503095Generic2025/08/23HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
枸橼酸苯海拉明布洛芬片 · No verified English name CYHS2502972Generic2025/08/14HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
葡萄糖酸钙锌口服溶液 · No verified English name CYHS1900826Generic2019/12/10HeFei Amvite Pharmaceutical Co.,LtdCDE ↗

Catalogue holder records

7 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.

DrugMarketing authorization holderManufacturerApproval numberApprovedCatalogue category (source text)View source
Memantine Hydrochloride OD TabletsHeFei Amvite Pharmaceutical Co.,LtdHeFei Amvite Pharmaceutical Co.,Ltd国药准字H202652882026/07/21Generic approved under the new chemical-drug registration classificationCDE ↗
Memantine Hydrochloride OD TabletsHeFei Amvite Pharmaceutical Co.,LtdHeFei Amvite Pharmaceutical Co.,Ltd国药准字H202652872026/07/21Generic approved under the new chemical-drug registration classificationCDE ↗
Memantine Hydrochloride OD TabletsHeFei Amvite Pharmaceutical Co.,LtdHeFei Amvite Pharmaceutical Co.,Ltd国药准字H202558202025/11/04Generic approved under the new chemical-drug registration classificationCDE ↗
Teriflunomide TabletsHeFei Amvite Pharmaceutical Co.,LtdHeFei Amvite Pharmaceutical Co.,Ltd国药准字H202448792024/09/10Generic approved under the new chemical-drug registration classificationCDE ↗
头孢克肟颗粒 · No verified English nameHeFei Amvite Pharmaceutical Co.,LtdAnhui An Ke Heng Yi Pharma Co., Ltd. romanized国药准字H202447812024/09/03Generic approved under the new chemical-drug registration classificationCDE ↗
Rupatadine Fumarate TabletsHeFei Amvite Pharmaceutical Co.,LtdHeFei Amvite Pharmaceutical Co.,Ltd国药准字H202430532024/01/16Generic approved under the new chemical-drug registration classificationCDE ↗
头孢地尼颗粒 · No verified English nameHeFei Amvite Pharmaceutical Co.,LtdAnhui An Ke Heng Yi Pharma Co., Ltd. romanized国药准字H202333972023/04/04Generic approved under the new chemical-drug registration classificationCDE ↗

Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.

API registrations

6 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.

NameCompany / applicantRegistration numberStatusSource update dateView source
枸橼酸苯海拉明 · No verified English nameHeFei Amvite Pharmaceutical Co.,LtdY20230001060I2023/11/24CDE ↗
特立氟胺 · No verified English nameHeFei Amvite Pharmaceutical Co.,LtdY20220001139A2025/05/10CDE ↗
富马酸卢帕他定 · No verified English nameHeFei Amvite Pharmaceutical Co.,LtdY20210001270A2024/07/24CDE ↗
他达拉非 · No verified English nameHeFei Amvite Pharmaceutical Co.,LtdY20210000269A2024/07/04CDE ↗
枸地氯雷他定 · No verified English nameHeFei Amvite Pharmaceutical Co.,LtdY20190008873A2026/05/18CDE ↗
地氯雷他定 · No verified English nameHeFei Amvite Pharmaceutical Co.,LtdY20180001686A2026/04/20CDE ↗

Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.

Co-applicant records

6 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.

This source was last successfully updated at 2026/11/18; current coverage may be incomplete.

Co-applicant records
Drug Acceptance numberApplication typeAcceptedCompany / applicantView source
注射用HY-022619 · No verified English name CXHL2400629New drug2024/06/27Hefei Yi Gong Pharmaceuticals Co., Ltd. romanized; HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
HY-021068片 · No verified English name CXHL2400330New drug2024/04/03Hefei Yi Gong Pharmaceuticals Co., Ltd. romanized; HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
HY-078020片 · No verified English name CXHL2300274New drug2023/03/07Hefei Yi Gong Pharmaceuticals Co., Ltd. romanized; HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
HY-078020片 · No verified English name CXHL2300273New drug2023/03/07Hefei Yi Gong Pharmaceuticals Co., Ltd. romanized; HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
HY-07170702软膏 · No verified English name CXHL2300129New drug2023/01/31Hefei Yi Gong Pharmaceuticals Co., Ltd. romanized; HeFei Amvite Pharmaceutical Co.,LtdCDE ↗
HY-07170702软膏 · No verified English name CXHL2300128New drug2023/01/31Hefei Yi Gong Pharmaceuticals Co., Ltd. romanized; HeFei Amvite Pharmaceutical Co.,LtdCDE ↗

How current is each source?

CDE acceptances and review
Last successful update: 2026/11/18 · Current coverage may be incomplete
Chemical-drug catalogue
Last successful update: 2026/11/18
API registrations
Last successful update: 2026/11/18
NMPA drug delivery notices
Last successful update: 2026/11/19

Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.

Listed by the company name as recorded in the source, without merging affiliated entities.

This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.

Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.

Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.

Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.